Expand APDN Menu
APDN MENU

APDN Latest Press Releases

-- July 25, 2024 --

Applied DNA Enters into Multi-Year Commercialization Agreement with Indus Group for Large-Scale Implementation of CertainT Cotton Traceability ACCESSWIRE 12:46 PM

-- July 18, 2024 --

U.S. Defense Logistics Agency Exercises 1-Year Option Period in Applied DNA Counterfeit Mitigation Contract ACCESSWIRE 10:04 AM

-- June 20, 2024 --

Applied DNA and Alphazyme Conclude Linea(TM) RNAP Manufacturing Scale-up Project, Deliver Substantial Improvement in Linea(TM) IVT Platform Economics ACCESSWIRE 9:20 AM

-- June 18, 2024 --

Applied DNA Partners with GenXys Health Care Systems to Deploy Clinical Decision Support System for Pharmacogenetic (PGx) Testing ACCESSWIRE 9:03 AM

-- June 13, 2024 --

Applied DNA Receives Approval for TR8(TM) Pharmacogenomic (PGx) Testing Service from New York State Department of Health ACCESSWIRE 9:02 AM

-- June 5, 2024 --

Applied DNA Announces Notice of Allowance for U.S. Patent Covering Fundamental Aspect of its Linea(TM) IVT Platform ACCESSWIRE 9:02 AM

-- May 28, 2024 --

Applied DNA Announces Pricing of $12 Million Public Offering ACCESSWIRE 9:31 AM

-- May 13, 2024 --

Institute of Hematology and Blood Transfusion (Prague) to Present on Successful Use of Applied DNA's Linea DNATM for the Non-Viral Manufacture of CAR T-Cell Therapy for Refractory AML ACCESSWIRE 8:59 AM

-- May 10, 2024 --

Applied DNA Announces Second Quarter Fiscal Year 2024 Financial Results ACCESSWIRE 4:06 PM
Applied DNA Regains Compliance with Nasdaq Minimum Bid Price Requirement ACCESSWIRE 9:22 AM

-- April 25, 2024 --

Applied DNA Awarded Contract by HDT Bio For Rapid Vaccine Development Program ACCESSWIRE 9:29 AM

-- April 22, 2024 --

Applied DNA Announces 1-For-20 Reverse Stock Split ACCESSWIRE 4:06 PM

-- March 14, 2024 --

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress ACCESSWIRE 10:01 AM